What does Neuphoria Therapeutics Inc. (NEUP) do?

Neuphoria Therapeutics Inc. (NEUP) is a publicly traded company.

What sector does NEUP operate in?

Neuphoria Therapeutics Inc. operates in the equity market. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find research and analysis for NEUP?

AlphaOS provides AI-assisted research, earnings transcripts, SEC filing analysis, opportunity scoring, and knowledge-graph relationships for Neuphoria Therapeutics Inc. (NEUP). All content is for research and education — not investment advice.

Neuphoria Therapeutics Inc. (NEUP)

US equity research on AlphaOS

Neuphoria Therapeutics Inc. operates in unknown sector.

Neuphoria Therapeutics Inc. key market context on AlphaOS includes Market capitalization: $23.29M; Recent price: $4.31. Figures update as market data and SEC filings are ingested.

Use this NEUP research hub for earnings transcripts, SEC filings, opportunity scoring, news, and knowledge-graph relationships. Content is for research and education only — not investment advice.

Key facts

Market cap:: $23.29M
Revenue:: $15.65M

Interactive charts, filings, and live quotes load below. Research & analysis only — not investment advice.

Intelligence coverage: 55%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

NEUP

Neuphoria Therapeutics Inc.

$4.31Jun 18, 2026

AI confidence 50% · prior close shown (market closed)

Loading earnings intelligence…

Opening stock page...

Fetching company snapshot, pricing, and intelligence.